Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study.
Autor: | Schmid P, Untch M, Kossé V, Bondar G, Vassiljev L, Tarutinov V, Lehmann U, Maubach L, Meurer J, Wallwiener D, Possinger K |
---|---|
Zdroj: | Journal of Clinical Oncology; 6/20/2007, Vol. 25 Issue 18, p2509-2515, 7p |
Databáze: | Supplemental Index |
Externí odkaz: |